E-Cigarettes + Nicotine Patch for Nicotine Addiction
Recruiting in Palo Alto (17 mi)
AC
Overseen byAmy C Janes, PhD
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Mclean Hospital
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine whether electronic cigarettes can reduce reactivity to smoking-related cues.
Research Team
AC
Amy C Janes, PhD
Principal Investigator
Mclean Hospital
Eligibility Criteria
This trial is for individuals aged 18-45 who smoke cigarettes daily, have a carbon monoxide level indicating regular smoking, and show some nicotine dependence. Participants must be willing to use Nicotine Replacement Therapy and e-cigarettes for 2-3 weeks, speak English, and pass an MRI safety screening.Inclusion Criteria
You have smoked cigarettes every day for the past 6 months.
I am willing to use Nicotine Replacement Therapy and e-cigarettes for 2-3 weeks.
You must give your written permission to take part in the study.
See 5 more
Treatment Details
Interventions
- Dual nicotine patch and electronic cigarette (Nicotine Replacement Therapy)
Trial OverviewThe study aims to see if using both nicotine patches and electronic cigarettes can help reduce the urge to smoke when exposed to cues related to smoking. It involves monitoring reactions during an MRI scan.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Dual nicotine patch and electronic cigaretteExperimental Treatment1 Intervention
Nicotine patch and the electronic cigarette will be administered.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mclean Hospital
Lead Sponsor
Trials
221
Recruited
22,500+
Dr. Susan M. Szulewski
Mclean Hospital
Chief Medical Officer since 2023
MD from University of Medical Sciences in Poznan, Poland; MBA from Heller School at Brandeis University
Dr. Scott L. Rauch
Mclean Hospital
Chief Executive Officer since 2006
MD from Harvard Medical School